S&P 500
7,508.40
+0.01%
Dow Jones
51,700.80
+0.20%
Nasdaq 100
30,474.60
+0.21%
Russell 2000
2,977.47
+0.07%
FTSE 100
10,416.70
+0.31%
Nikkei 225
73,244.20
+1.75%

Investing

CBIO logo Glycomimetics : CBIO

CBIO

Stock Data

$17.69

Change down

$0.52 (2.86%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative protease therapeutics that target hemostasis and complement regulation. The company is poised to address significant unmet medical needs through its promising pipeline, which includes novel candidates designed to tackle serious conditions associated with blood coagulation and immune response. Leveraging advanced research and proprietary technologies, Crescent Biopharma aims to deliver transformative solutions within the biopharmaceutical sector, positioning itself as a key player in the evolving landscape of therapeutic advancements.

All Glycomimetics Articles

1 Article